Ginkgo Bioworks appoints Steven Coen as Chief Accounting Officer; Marie Fallon resigns

Ginkgo Bioworks Holdings, Inc.

Marie Fallon resigns as CAO effective May 15, 2023; she will remain through June 2 and then as consultant.
Steven Coen appointed CAO effective same date, with annual base salary of $400,000 and $1.5M equity grant vesting over 4 years.
Coen brings over 30 years experience, most recently Corporate VP & Controller at Charles River Laboratories (annual revenues ~$4B).
Fallon's resignation is personal, not due to any disagreement with the company.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Marie E. Fallon

Chief Accounting Officer

DNA · Ginkgo Bioworks Holdings, Inc.

Effective: 2023-05-15
Successor: Steven P. Coen
Filed: May 5, 2023, 7:59 PM ET

Marie E. Fallon informed Ginkgo Bioworks Holdings, Inc. (the “Company”) on May 1, 2023 of her intent to resign from her role as Chief Accounting Officer of the Company, effective May 15, 2023.

Appointed

Steven P. Coen

Chief Accounting Officer

DNA · Ginkgo Bioworks Holdings, Inc.

Effective: 2023-05-15
Filed: May 5, 2023, 7:59 PM ET

In connection with Ms. Fallon’s resignation and subject to the approval of the Company’s Board of Directors, on May 5, 2023, the Company appointed Steven P. Coen, age 57, as its Chief Accounting Officer, effective May 15, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Marie E. Fallon resigned as Chief Accounting Officer at Ginkgo Bioworks Holdings, Inc..

Action: resigned
Role: Chief Accounting Officer

Exact text from the filing

Marie E. Fallon informed Ginkgo Bioworks Holdings, Inc. (the “Company”) on May 1, 2023 of her intent to resign from her role as Chief Accounting Officer of the Company, effective May 15, 2023.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Steven P. Coen was appointed as Chief Accounting Officer at Ginkgo Bioworks Holdings, Inc..

Action: appointed
Role: Chief Accounting Officer

Exact text from the filing

In connection with Ms. Fallon’s resignation and subject to the approval of the Company’s Board of Directors, on May 5, 2023, the Company appointed Steven P. Coen, age 57, as its Chief Accounting Officer, effective May 15, 2023.

View on SEC.gov

Ginkgo Bioworks Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-018074

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.